B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review.

  title={B-vitamins and fatty acids in the prevention and treatment of Alzheimer's disease and dementia: a systematic review.},
  author={Alan D. Dangour and Peter Whitehouse and Kevin Rafferty and Stephen A. Mitchell and Lesley Smith and Sophie Hawkesworth and Bruno Vellas},
  journal={Journal of Alzheimer's disease : JAD},
  volume={22 1},
The increasing worldwide prevalence of dementia is a major public health concern. Findings from some epidemiological studies suggest that diet and nutrition may be important modifiable risk factors for development of dementia. In order to evaluate the strength of the available evidence of an association of dietary factors with dementia including Alzheimer's disease (AD), we systematically searched relevant publication databases and hand-searched bibliographies up to end July 2007. We included… 

Figures from this paper

Nutrition and the Risk of Alzheimer's Disease

The evidence linking many nutrients, foods, and dietary patterns to AD, including adherence to a healthy diet, the Japanese diet, and the Mediterranean diet is associated with a lower risk of AD.

Nutrition and Cognitive Decline in Older Persons: Bridging the Gap Between Epidemiology and Intervention Studies

The aim of this chapter is to analyze the reasons for such inconsistent results in order to make recommendations for well-designed RCTs assessing the impact of nutrition for the prevention or treatment of cognitive decline.

The role of nutrition in Alzheimer’s disease: epidemiological evidence

  • M. Morris
  • Biology
    European journal of neurology
  • 2009
This review will focus on epidemiological evidence investigating the relationship between nutrition and AD, focusing particularly on the roles of dietary fats and antioxidants.

Omega 3 fatty acid for the prevention of cognitive decline and dementia.

The available trials showed no benefit of omega-3 PUFA supplementation on cognitive function in cognitively healthy older people and the main reported side-effect was mild gastrointestinal problems.

Nutrition and prevention of Alzheimer’s dementia

The current review focuses on several key nutritional compounds and dietary modifications that have been studied in humans, and further discusses the rationale underlying their potential utility for the prevention and treatment of AD.

The Association between the Mediterranean Dietary Pattern and Cognitive Health: A Systematic Review

Results from this review indicate that the Mediterranean diet could play a major role in cognitive health and risk of Alzheimer’s disease and dementia.

Lifestyle-related Risk Factors Associated with Alzheimer's Disease: A Systematic Review of the Literature

Results of the de novo systematic review indicated that the available evidence was inadequate to suggest an association between stress and risk of AD, and too few studies were identified in the updated systematic review on Mediterranean diet adherence to allow for definitive conclusions.

Effect of vitamin intake on cognitive decline in older adults: Evaluation of the evidence

Evaluation of the totality of the currently available evidence indicates that intake of the above vitamins, either as a monotherapy, or in combination with other vitamins, has no clinically-relevant effect on delaying cognitive decline or delaying the onset of dementia in older adults.

Mediterranean diet and dementia of the Alzheimer type.

This review will focus on the latest developments and findings in the ongoing research investigating the relationship between Mediterranean diet and its major constituents in AD onset and progression.

Dietary folate and vitamins B-12 and B-6 not associated with incident Alzheimer's disease.

Dietary intakes of folate, Vitamin B-12, or vitamin B-6 do not appear to be associated with the development of Alzheimer's disease.

Diet and Alzheimer’s disease

The existing evidence does not support the recommendation of specific supplements, foods, or diets for the prevention of AD.

Dietary factors and Alzheimer's disease

The Efficacy of Omega–3 Fatty Acids on Cognitive Function in Aging and Dementia: A Systematic Review

Limited evidence suggests a possible association between omega–3 fatty acids and reduced risk of dementia, but the available data are insufficient to draw strong conclusions.

Dietary fatty acids in dementia and predementia syndromes: Epidemiological evidence and possible underlying mechanisms

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial.

Although the vitamin supplement regimen was effective in reducing homocysteine levels, it had no beneficial effect on the primary cognitive measure, rate of change in ADAS-cog score during 18 months, and this regimen of high-dose B vitamin supplements does not slow cognitive decline in individuals with mild to moderate AD.

Omega-3 fatty acids and risk of cognitive impairment and dementia.

The hypothesis that omega-3 polyunsaturated fatty acids play a protective role in cognitive function and dementia is not supported.

Heterogeneity and lack of good quality studies limit association between folate, vitamins B-6 and B-12, and cognitive function.

Although the majority of studies indicated that low blood folate concentrations predicted poorer cognitive function, data supporting this association were limited because of the heterogeneity in cognition-assessment methodology, and scarcity of good quality studies and standardized threshold levels for categorizing low B-vitamin status.

Homocysteine and folate as risk factors for dementia and Alzheimer disease.

Elevated plasma tHcy concentrations and low serum folate concentrations are independent predictors of the development of dementia and Alzheimer disease in an elderly population.

Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association

The existing data favor a role for long-chain omega-3 fatty acids in slowing cognitive decline in elderly individuals without dementia, but not for the prevention or treatment of dementia (including AD).